期刊文献+

健康状态效用值测量研究报告规范及对比研究

Reporting Guidelines for and Comparative Study of Health State Utility Values Estimation
下载PDF
导出
摘要 目的:比较研究国际上权威机构开发的健康状态效用值(HSUVs)测量研究报告规范,为我国开展HSUVs测量研究提供报告规范参考。方法:基于国内外文献,梳理4个HSUVs测量研究报告规范的发展历史及应用情况,对其适用范围和条目内容进行比较分析。结果:4个HSUVs测量研究报告规范的开发目的不同,适用范围不同,条目内容的侧重点也有所不同;HSUVs测量研究报告规范清单须包含5个方面16个条目。结论:在开展HSUVs测量研究时,应根据研究主题参考合适的规范,也可联合使用多种报告规范。 Objective To study reporting guidelines for the health state utility values(HSUVs)estimation for advancing the standardization of the implementation and reporting of HSUVs estimation.Methods This study summarized the development history and application of four reporting guidelines,and compared their applicable conditions and specific items.Results These four guidelines showed differences in their goals,applicable conditions,and focus of specific items.These indicated that a checklist of reporting guidelines for HSUVs estimation should contain 5 aspects and 16 items.Conclusions It is suggested to adopt suitable guideline according to study aims.A joint use of different guidelines is also advocated.
作者 卢钰琼 代展菁 路云 常峰 LU Yuqiong;DAI Zhanjing;LU Yun;CHANG Feng(School of International Pharmaceutical Business,China Pharmaceutical University,Nanjing Jiangsu 211198,China;不详)
出处 《卫生经济研究》 北大核心 2022年第7期68-73,共6页
基金 国家自然科学基金项目资助(71673298)。
关键词 健康状态效用值 经济学评价 报告规范 health state utility values(HSUVs) economic evaluation reporting guideline
  • 相关文献

参考文献2

二级参考文献4

  • 1Azuma MK, Ikeda S. Investigation of Evidence Sources for Health-Related Quality of Life in Cost-Utility Analysis of Pharmaceuticals in Japan[J]. Value in Health Regional Issues,2014,(3) : 190-196.
  • 2Nafees B, Stafford M, Gavriel S, Bhalla S, Watkins J. Health state utilities for non small cell lung cancer[J]. Health Qual Life Outcomes, 2008,(6):84.
  • 3Carlson J J, Garrison LP, Ramsey SD, Veenstra DL. The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer[J]. Value Health,2009,12(1):20-27.
  • 4<中国药物经济学评价指南>课题组,刘国恩,胡善联,吴久鸿.中国药物经济学评价指南(2011版)[J].中国药物经济学,2011(3):6-48. 被引量:286

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部